Mark J. Pykett
2014
In 2014, Mark J. Pykett earned a total compensation of $857.4K as Chief Executive Officer at Navidea Biopharmaceuticals, a 24% decrease compared to previous year.
Compensation breakdown
| Option Awards | $279,468 |
|---|---|
| Salary | $166,250 |
| Other | $411,669 |
| Total | $857,387 |
Pykett received $411.7K in other compensation, accounting for 48% of the total pay in 2014.
Pykett also received $279.5K in option awards and $166.3K in salary.
Rankings
In 2014, Mark J. Pykett's compensation ranked 8,243rd out of 13,032 executives tracked by ExecPay. In other words, Pykett earned more than 36.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,243 out of 13,032 | 37th |
Division Manufacturing | 3,052 out of 4,965 | 39th |
Major group Chemicals And Allied Products | 1,038 out of 1,690 | 39th |
Industry group Drugs | 817 out of 1,369 | 40th |
Industry In Vitro and In Vivo Diagnostic Substances | 36 out of 72 | 50th |
Source: SEC filing on June 5, 2015.
Pykett's colleagues
We found six more compensation records of executives who worked with Mark J. Pykett at Navidea Biopharmaceuticals in 2014.
2014
Ricardo Gonzalez
Navidea Biopharmaceuticals
Chief Executive Officer
2014
Thomas Tulip
Navidea Biopharmaceuticals
President and Chief Business Officer
2014
Cornelia Reininger
Navidea Biopharmaceuticals
Chief Medical Officer
2014
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2014
Brent Larson
Navidea Biopharmaceuticals
Chief Financial Officer
2014
William Regan
Navidea Biopharmaceuticals